Notes from conference calls between Bremner Capital Management and Tekmira Pharmaceuticals discussing the TKM-Ebola product, its distribution model, and financial projections. The discussions also cover Tekmira's relationship with the US government and their PR strategy in light of the Ebola outbreak.
documents/EFTA01197772.pdf
{}